This study aims to evaluate the improvement of life qualities of elderly cancer patients in advanced stage treated with BSD2000 deep hyperthermia combined with chemotherapy. The short-term efficacy and adverse effects of the treatment were observed and strategies for clinical care were discussed. Forty- one patients with advanced cancer received BSD2000 deep hyperthermia combined with chemotherapy in Beijing Hospital from October 2009 to March 2013. Before treatment, their life qualities were evaluated. After treatment, the improvement of their life qualities was observed, and theefficacy and adverse effects of the treatment were evaluated. Psychological care and preparations were taken before treatment. Careful monitoring and treatment for adverse effects were given during treatment. The results show that the lifequalities of the 41 patients were improved apparently, and the pain was reduced. The overall efficacy of the treatment was 58.54% withno severe side-effects. BSD2000 deep hyperthermia combined with chemotherapy is able to improve the life qualities of elderly cancer patients in an advanced stage with satisfactory efficacy and acceptable adverse effects. Psychological care and careful monitoring help to reduce the incidence of complications during the treatment and promote recovery of the patients.
ZHAO Tingting
,
DING Li
,
WANG Hui
,
WU Xiaonan
. Clinical Research Improvement of Life Qualities by BSD2000 Deep Hyperthermia Combined with Chemotherapy in Elderly Cancer Patients and Clinical Care[J]. Science & Technology Review, 2014
, 32(30)
: 63
-66
.
DOI: 10.3981/j.issn.1000-7857.2014.30.011
[1] Zhan H J. Research of tumor thermotherapy[J]. Foreign Medicine Science Oncology Section, 2005, 32(1): 35-37.
[2] Wust P, Hidebrandt B, Streenivasa G, et al. Hyperthermia in combined treatment of cancer[J]. Lancet Oncology, 2002, 3(8): 489-497.
[3] 彭楠, 赵彼得. 临床肿瘤热疗[M]. 北京: 人民军医出版社, 2002: 25-35, 66-68. Peng Nan, Zhao Bide. Clinical Tumor Hyperthemia[M]. Beijing: People's Military Medcial Press, 2002: 25-35, 66-68.
[4] Multhoff G, Botzler C, Wiesnet M, et al. A stress-indcible 72-kDa heatshock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cell[J]. International Journal of Cancer, 1995, 61(2): 272-279.
[5] Basu S, Binder R J, Suto R, et al. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kB pathway[J]. International Immunology, 2000, 12(11): 1539-1546.
[6] 陈敬华, 焦顺昌. 肿瘤热化疗生物机制及其临床应用[J]. 中华肿瘤防治杂志, 2006, 13(23): 1828-1830． Chen Jinghua, Jiao Shunchang. Bio-mechanism of tumor thermochemotherapy and its clinical applications[J]. Chinese Journal of Cancer Pre? vention and Treatment, 2006, 13(23): 1828-1830.
[7] Kampinga H H. Cell biological effects of hyperthermia alone or combined with radiation or drugs: A short introduction to newcomers in the field[J]. International Journal of Hyperthermia, 2006, 22(3): 191-196.
[8] Takahashi I, Emi Y, Hasuda S, et al. Clinical application of hyperthermia combined with anticancer drugs for the treatment of solid tumors[J]. Surgery, 2002, 131(S1): 78-84.
